Complexo Hospitalario Universitario de Ferrol
Centro de atención
![Foto de Complexo Hospitalario Universitario de Ferrol](/img/noimage.png)
![Foto de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas](/img/noimage_org.png)
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (20)
2024
-
Current barriers to initiating insulin therapy in individuals with type 2 diabetes
Frontiers in Endocrinology, Vol. 15
-
Ultrasound Cut-Off Values for Rectus Femoris for Detecting Sarcopenia in Patients with Nutritional Risk
Nutrients, Vol. 16, Núm. 11
2023
-
Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital
Endocrine Practice, Vol. 29, Núm. 11, pp. 919-927
-
Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition
Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102
-
Expert Consensus on Morphofunctional Assessment in Disease-Related Malnutrition. Grade Review and Delphi Study
Nutrients, Vol. 15, Núm. 3
-
Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes
Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1326-1336
-
Physical activity patterns in type 1 diabetes in Spain: The SED1 study
BMC Sports Science, Medicine and Rehabilitation, Vol. 15, Núm. 1
2022
-
Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy
Diabetes Therapy, Vol. 13, Núm. 7, pp. 1281-1298
-
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888
2021
-
Inpatient Hyperglycemia Management and COVID-19
Diabetes Therapy, Vol. 12, Núm. 1, pp. 121-132
-
Leading factors for weight gain during covid-19 lockdown in a Spanish population: A cross-sectional study
Nutrients, Vol. 13, Núm. 3, pp. 1-12
-
Time-in-range for monitoring glucose control: Is it time for a change?
Diabetes Research and Clinical Practice, Vol. 177
2020
-
Consequences of COVID-19 on people with diabetes
Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 6, pp. 355-356
-
Factors Accounting for Obesity and Its Perception among the Adult Spanish Population: Data from 1,000 Computer-Assisted Telephone Interviews
Obesity Facts, Vol. 13, Núm. 4, pp. 322-332
-
Fish oil enriched intravenous lipid emulsions reduce triglyceride levels in non-critically ill patients with TPN and type 2 diabetes. a post-hoc analysis of the INSUPAR study
Nutrients, Vol. 12, Núm. 6
-
Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes
Diabetes Research and Clinical Practice, Vol. 166
-
Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial
Clinical Nutrition, Vol. 39, Núm. 2, pp. 388-394
-
Risk factors for hypoglycemia in inpatients with total parenteral nutrition and type 2 diabetes: A post hoc analysis of the InSUPAR study
Endocrine Practice, Vol. 26, Núm. 6, pp. 604-611
2016
-
A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome
Endocrine Pathology, Vol. 27, Núm. 2, pp. 142-146
2012
-
Prediction of whole-body and segmental body composition by bioelectrical impedance in morbidly obese subjects
Obesity Surgery, Vol. 22, Núm. 4, pp. 587-593